The global bronchitis clinical trials landscape reveals opportunities in optimizing trial locations, enhancing enrollment strategies, and investing in promising drugs. By analyzing trial phases, ...
The report on "Amyloidosis - Global Clinical Trials Review, 2025" highlights key opportunities by providing insights on trial locations, status, and sponsor types. It aids in strategic investment ...
SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 14, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on the development of CID-103, a potential ...
Third quarter 2025 net revenues were $17.6 million Emrosi total prescriptions increased 146% over the second quarter of 2025 Emrosi net revenues were $4.9 million Company to hold conference call today ...
Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a Florida-based provider of residential solar and commercial long-duration energy-storage solutions, today reported financial ...
Precious Metal Gems have been some of the most influential, sought-after, and valuable cards of the last 30 years.
CALGARY, AB, Nov. 13, 2025 /CNW/ - Tidewater Renewables Ltd. ("Tidewater Renewables" or the "Corporation") (TSX: LCFS) is ...
LAS VEGAS, NV / ACCESS Newswire / November 14, 2025 / Healthy Extracts Inc. , a leader in plant-based nutraceutical innovations, reported results for the third quarter and nine months ended September ...
DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) ("DPM" or the "Company") announced its operating and financial results for the third quarter and first ...
EAST HANOVER, N.J., Nov. 14, 2025 /PRNewswire/ — FGI Industries Ltd. (Nasdaq: FGI) (“FGI” or the “Company”), a leading global supplier of kitchen and bath products, today announced results for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results